Health Care & Life Sciences » Pharmaceuticals | Corline Biomedical AB

Corline Biomedical AB

Corline Biomedical AB
Stock Exchange First North Sweden
EPS
SEK0.45
Market Cap
SEK378.6 M
Shares Outstanding
15.77 M
Public Float
-

Profile

Address
Lefflersgatan 5
Uppsala UP 754 50
Sweden
Employees -
Website http://www.corline.se
Updated 09/14/2018
Corline Biomedical AB engages in the research, development, and commercialization of heparin based solutions. Its products intend to improve kidney transplantation, cell therapies, and applications. It operates under the following trademarks: CHC, Renaparin, Cytoparin, and CHS.

Financials

View All

Henrik Krook
Non-Executive Director
Lars Fredrik Sunnanväder
Non-Executive Director